ID

34425

Description

Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders The purpose of this form is to document the current medical condition of the subject. It should be filled out at the screening visit.

Mots-clés

Versions (3)

1. 11/01/2019 11/01/2019 -
2. 13/01/2019 13/01/2019 -
3. 17/01/2019 17/01/2019 -

Détendeur de droits

GlaxoSmithKline

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence